Sartorius Stedim Biotech SA (DIM) — Cash Flow-to-Debt Ratio
Sartorius Stedim Biotech SA (DIM) has a Cash Flow-to-Debt Ratio of 0.04x as of June 2026, meaning its operating cash flow of €129.50 Million could theoretically repay 0% of its total liabilities (€3.67 Billion) in one year. See Sartorius Stedim Biotech SA financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Sartorius Stedim Biotech SA Cash Flow-to-Debt Ratio (2005–2025)
Historical debt coverage capacity for Sartorius Stedim Biotech SA across 21 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Sartorius Stedim Biotech SA.
Annual Cash Flow-to-Debt Ratio for Sartorius Stedim Biotech SA (2005–2025)
Year-by-year debt coverage analysis for Sartorius Stedim Biotech SA. Check earnings quality score of Sartorius Stedim Biotech SA to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.14x | €538.60 Million | €3.89 Billion | ▼ -28.1% |
| 2024 | 0.19x | €815.10 Million | €4.23 Billion | ▲ +30.7% |
| 2023 | 0.15x | €746.40 Million | €5.07 Billion | ▼ -38.6% |
| 2022 | 0.24x | €612.30 Million | €2.55 Billion | ▼ -23.5% |
| 2021 | 0.31x | €695.97 Million | €2.22 Billion | ▲ +19.4% |
| 2020 | 0.26x | €416.88 Million | €1.59 Billion | ▼ -45.5% |
| 2019 | 0.48x | €310.13 Million | €642.79 Million | ▲ +11.8% |
| 2018 | 0.43x | €227.29 Million | €526.59 Million | ▲ +29.6% |
| 2017 | 0.33x | €174.69 Million | €524.45 Million | ▼ -8.1% |
| 2016 | 0.36x | €156.66 Million | €432.29 Million | ▲ +6.3% |
| 2015 | 0.34x | €142.79 Million | €418.92 Million | ▲ +12.8% |
| 2014 | 0.30x | €111.31 Million | €368.25 Million | ▲ +30.6% |
| 2013 | 0.23x | €90.11 Million | €389.39 Million | ▲ +69.9% |
| 2012 | 0.14x | €48.93 Million | €359.14 Million | ▼ -26.9% |
| 2011 | 0.19x | €60.59 Million | €325.04 Million | ▼ -25.4% |
| 2010 | 0.25x | €72.76 Million | €291.27 Million | ▼ -25.3% |
| 2009 | 0.33x | €91.86 Million | €274.66 Million | ▲ +98.8% |
| 2008 | 0.17x | €47.23 Million | €280.70 Million | ▲ +79.7% |
| 2007 | 0.09x | €26.02 Million | €277.96 Million | ▼ -62.3% |
| 2006 | 0.25x | €51.72 Million | €208.41 Million | ▲ +21.2% |
| 2005 | 0.20x | €43.85 Million | €214.18 Million | — |